You are here: Industry Insights > FDA

News List

FDA Warns Companies Marketing Unproven Products, Derived From Marijuana, That Claim To Treat, Cure C americanpharmaceuticacreview
November 03, 2017
The U.S. Food and Drug Administration has issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.
FDA issues warnings in crackdown on baseless cannabis miracle cures pharmafile
November 03, 2017
The U.S. Food and Drug Administration has issued a warning about cannabis-based treatment
Indivior's opioid addiction treatment recommended by FDA advisory panel pharmafile
November 02, 2017
Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges that an experimental drug from Indivior which is designed to treat opioid addiction has been recommended by an advisory panel to the FDA
FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure worldpharmanews
November 02, 2017
As part of the U.S. Food and Drug Administration's ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer w
FDA approves Calquence for adults with mantle cell lymphoma europeanpharmaceuticalreview
November 02, 2017
The FDA has granted accelerated approval to Calquence for the treatment of adults with mantle cell lymphoma…
New dosing for Janssen's Xarelto approved by FDA to reduce the risk of VTE europeanpharmaceuticalreview
October 31, 2017
The FDA has approved the 10 mg once-daily dose of Xarelto, for reducing the continued risk of VTE.
Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets biospectrumasia
October 30, 2017
Lupin’s Carbidopa Tablets, 25 mg is the AB rated generic equivalent of Aton Pharma, Inc.’s Lodosyn Tablets, 25 mg
FDA approves Procainamide HCL Injection, USP for treatment of ventricular arrhythmias biospectrumasia
October 30, 2017
Procainamide hydrochloride injection is indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening.
FDA rejects PTC’s DMD drug Translarna pharmatimes
October 27, 2017
PTC Therapeutics will need to carry out at least one further trial to demonstrate the effectiveness of its Duchenne Muscular Dystrophy therapy Translarna if it is to have a chance of bagging its approval in the US.
FDA collaboration uses Organs-on-Chips to improve drug development europeanpharmaceuticalreview
October 27, 2017
FDA collaboration will characterise the performance of Organs-on-Chips as a platform for potential use in drug development and regulatory evaluation…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page